1-2 of 2
Rachel Ibbotson, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Giles Best, PhD, Anne Gardiner, BSc, Rachel Ibbotson, PhD, Aneela Majid, PhD, Renata Walewska, MD, Belinda Austen, MD, Tanja Stankovic, PhD, Martin Dyer, MD, David Graham Oscier, MD
Journal: Blood
Blood (2006) 108 (11): 2795.
https://doi.org/10.1182/blood.V108.11.2795.2795
Published: 2006
Journal Articles

Defining the 10 Year Risk of Disease Progression in Stage A0 CLL.

Anne Gardiner, BSc, Zadie Davis, MSc, Parker Anton, BSc, Giles Best, PhD, Rachel Ibbotson, PhD, Sarah Mould, BSc, Sharron Glide, BSc, Peter Thomas, PhD, Jenny Orchard, MD, David Graham Oscier, MD
Journal: Blood
Blood (2006) 108 (11): 2772.
https://doi.org/10.1182/blood.V108.11.2772.2772
Published: 2006